BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 23, 2026
Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

With Positive AD 237 Data, Vectura Planning AIM IPO

May 19, 2004
By Nuala Moran

Celltech Agrees To Buyout By UCB In $2.7B Cash Deal

May 19, 2004
By Nuala Moran
LONDON - Celltech Group plc, the UK's largest biotechnology company, has agreed to be taken over by UCB SA, of Brussels, Belgium, in an all-cash deal that values Celltech at about £1.5 billion (US$2.7 billion).
Read More

Chiron Spins Powder Injection Technology Into PowderMed Ltd.

May 19, 2004
By Nuala Moran

Celltech Agrees To Buyout By UCB For $2.7B In Cash

May 19, 2004
By Nuala Moran
LONDON - Celltech Group plc, the UK's largest biotechnology company, has agreed to be taken over by UCB SA, of Brussels, Belgium, in an all-cash deal that values Celltech at about £1.5 billion (US$2.7 billion). (BioWorld Today)
Read More

SkyePharma Signs First Horizon To Potential $50M Marketing Deal

May 18, 2004
By Nuala Moran

Chiron Spins Powder Injection Technology Into PowderMed Ltd.

May 18, 2004
By Nuala Moran
LONDON - Chiron Corp. is spinning out the DNA vaccines technology it acquired when it took over PowderJect Pharmaceuticals plc to a team of former PowderJect managers. (BioWorld Today)
Read More

SkyePharma Signs First Horizon To Potential $50M Marketing Deal

May 18, 2004
By Nuala Moran

Chiron Spins Powder Injection Technology Into PowderMed Ltd.

May 18, 2004
By Nuala Moran
LONDON - Chiron Corp. is spinning out the DNA vaccines technology it acquired when it took over PowderJect Pharmaceuticals plc to a team of former PowderJect managers. (BioWorld Today)
Read More

Lectus Gets Investment From Takeda For PFD Protein Work

May 12, 2004
By Nuala Moran

Lectus Gets Investment From Takeda For PFD Protein Work

May 12, 2004
By Nuala Moran
View All Articles by Nuala Moran

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing